Modification of NY J81823, NY 891019, and NY 810507; Tariff classification of Propafenone Hydrochloride
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- Additionally, the World Customs Organization (“WCO”) INN DCI list4 classifies propafenone in the six-digit heading 2922.19. * * * There is no dispute that propafenone hydrochloride is properly classified under heading 2922, HTSUS.
Ruling text
This is to inform you that U.S. Customs and Border Protection (“CBP”) has reconsidered New York Ruling Letters (“NY”) J81823, dated March 12, 2003, and issued to Ren-Pharm International, Ltd.; NY 891019 dated November 5, 1993, and issued to Interchem Corporation; and NY 810507, dated May 26, 1995, and issued to Interchem Corporation, regarding the classification of propafenone hydrochloride under the Harmonized Tariff Schedule of the United States (“HTSUS”).
In each case, CBP classified propafenone hydrochloride in subheading 2922.50.14, HTSUS, which provides for “Oxygen-function amino-compounds: Amino-alcohol-phenols, amino- acid-phenols and other amino-compounds with oxygen function: Aromatic: Other: Cardiovascular drugs.” We have determined that the three CBP rulings are partly in error, and that the proper classification of propafenone hydrochloride is subheading 2922.19.09, HTSUS, which provides for “Oxygen-function amino-compounds: Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters: salts thereof: Other: Aromatic: Drugs.” Accordingly, for the reasons set forth below, we are modifying NY J81823, NY 891019, and NY 810507, solely with respect to the classification of propafenone hydrochloride.1 1 Each ruling letter classified multiple types of drugs.
This modification only concerns the classification of propafenone hydrochloride. 1 Pursuant to section 625(c)(1), Tariff Act of 1930 (19 U.S.C. § 1625(c)(1)), as amended by section 623 of Title VI (Customs Modernization) of the North American Free Trade Agreement Implementation Act (Pub. L. 103-182, 107 Stat. 2057), a notice of the proposed action was published in the Customs Bulletin, Volume 59, No. 5, on January 29, 2025. No comments were received in response to this notice.
FACTS: Propafenone hydrochloride is not described in NY J81823, NY 891019, and NY 810507 beyond its function as an anti-arrhythmic drug. Propafenone hydrochloride is an oral medication taken to treat certain types of irregular heartbeat; it is used to restore normal heart rhythm and maintain a regular, steady heartbeat.2 Chemically, propafenone hydrochloride is 2'-[2-Hydroxy-3- (propylamino)- propoxy]-3-phenylpropiophenone hydrochloride, with a molecular weight of 377.92.
The molecular formula is C21H27NO3•HCl.3 Propafenone hydrochloride occurs as colorless crystals or white crystalline powder with a very bitter taste. It is slightly soluble in water (20° C), chloroform, and ethanol. In CBP Laboratory report NY20190073, propafenone hydrochloride is described as a whole with following functional groups: aromatic, secondary amine, ether, phenol, hydroxyl, and ketone. Of these, the following are oxygen groups: ketone, ether, phenol, and hydroxyl.
The lab report further states “[t]he only oxygen-containing functional group relevant to classification is the alcohol, being the only oxygen function present in that part of the molecule between the amine and the ether function.” The Chemical Abstract Service (“CAS”) registry number of propafenone hydrochloride is 34183-22-7. The CAS number of propafenone is 54063- 53-5.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (H306891).